Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-04-30 | Ms. Finney holds a B.A. degree in risk management and insurance from the University of Georgia as well as an MBA degree from Golden Gate University in San Francisco. We believe Ms. Finney’s impressive business leadership skills and experience in building and running global financial organizations will bring valuable expertise and perspective to the Board. |
| 2019-04-30 | She holds a BA degree in risk management and insurance from the University of Georgia as well as an MBA degree from Golden Gate University in San Francisco. |
| Filing Date | Source Excerpt |
|---|---|
| 2016-04-04 | Elisha W. Finney Ms. Finney, 54, has been a director since January 2016 and serves on the Nominating/Corporate Governance Committee and the Audit Committee. |
| 2017-04-10 | Elisha W. Finney Ms. Finney, 55, has been a director since January 2016, serves as Chair of the Compensation Committee and is a member of the Nominating/Corporate Governance Committee and the Audit Committee. |
| 2018-04-05 | Elisha W. Finney Ms. Finney, 56, has been a director since January 2016, serves as Chair of the Audit Committee and is a member of the Nominating/Corporate Governance Committee. 2017 Director Compensation Table Elisha Finney $78,500 fees earned or paid in cash $75,145 stock awards $75,025 option awards $0 other $228,670 total |
| 2019-04-05 | Ms. Finney, 57, has been a director since January 2016, and serves as Chair of the Audit Committee. |
| 2020-04-03 | Elisha W. Finney, Chair of the Audit Committee, 2019 total compensation $267,014. |
| 2021-04-01 | Elisha W. Finney Ms. Finney, 59, has been a director since January 2016, and serves as Chair of the Audit Committee. |
| 2022-04-04 | Ms. Finney, 60, has been a director since January 2016, and serves as Chair of the Nominating and Governance Committee and is a member of the Audit Committee. Ms. Finney, now retired, was named Vice President, Finance and CFO of Varian Medical Systems in April 1999. In January 2005, she was promoted to Senior Vice President and given additional management responsibility for the Corporate Information Systems group. She was named Executive Vice President in February 2012. Varian Medical Systems is a leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. Ms. Finney managed a worldwide staff of 400. Her management responsibilities included corporate accounting; corporate communications and investor relations; internal financial and compliance audit; risk management; tax and treasury, and corporate information systems. Ms. Finney joined Varian as risk manager in 1988 and has assumed a wide variety of finance functions over her last 29 years with the company. Prior to joining Varian, Ms. Finney was with the Fox Group in Foster City, CA, and Beatrice Foods, a major food processing company, in Chicago, IL. Ms. Finney has served on the boards of: NanoString Technologies, a company that specializes in development of cancer diagnostics tools, since May 2017; Mettler Toledo, a multinational manufacturer of scales and analytical instruments, since November 2017; and Cutera, Inc. a global provider of laser and other energy-based aesthetic systems, from November 2017 to May 2019. Ms. Finney previously served on the boards of directors of: Laserscope from August 2005 until July 2006 when Laserscope was sold to American Medical Systems; Thoratec, a developer, manufacturer and marketer of proprietary medical devices for mechanical circulatory support from July 2007 to May 2013; Altera Corporation, a manufacturer of programmable logic devices from September 2011 until December 2015, when Altera was sold to Intel; and iRobot Corporation, a robotics technology company, from January 2017 to November 2021. The Board believes Ms. Finney should serve as a director due to her extensive knowledge and experience in the medical industry and her financial knowledge and experience, particularly with respect to her service on the Audit Committee. |
| 2023-04-04 | Ms. Finney, 61, has been a director since January 2016, and serves as Chair of the Nominating Committee and is a member of the Audit Committee. ... The Board has determined that directors Messrs. Greenberg, Abbey, and Hoffmeister, Ms. Finney, Ms. Hernandez and Ms. Kennedy qualify as independent under NASDAQ Listing Rules. |
| 2024-04-02 | Ms. Finney, 62, has been a director since January 2016, and serves as Chair of the Nominating Committee and is a member of the Audit Committee. ... The Board believes Ms. Finney should serve as a director due to her extensive knowledge and experience in the medical industry and her financial knowledge and experience, particularly with respect to her service on the Audit Committee. |
| 2025-04-03 | Ms. Finney, 63, has been a director since January 2016, and serves as Chair of the Nominating Committee and is a member of the Audit Committee. ... The Board believes Ms. Finney should serve as a director due to her extensive knowledge and experience in the medical industry and her financial knowledge and experience, particularly with respect to her service on the Audit Committee. |
Data sourced from SEC filings. Last updated: 2026-02-03